Intrathecal Chemokine Synthesis in Mild Cognitive Impairment and Alzheimer Disease

Clinical diagnosis of Alzheimer's disease: Report of the NINCDS‐ADRDA Work Group* under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915 · see citing works

Mild Cognitive Impairment: Clinical Characterization and Outcome

Petersen, R. C., Smith, G. E., Waring, S. C., Ivnik, R. J., Tangalos, E. G., & Kokmen, E. (1999) · Archives of Neurology · doi:10.1001/archneur.56.3.303 · Cited by 8,980 · see citing works

Mild cognitive impairment as a diagnostic entity

Petersen, R. C. (2004) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2004.01388.x · Cited by 7,864 · see citing works

Current concepts in mild cognitive impairment

Petersen, R. C., Doody, R., Kurz, A., Mohs, R. C., Morris, J. C., Rabins, P. V., Ritchie, K., Rossor, M., Thal, L., & Winblad, B. (2001) · Archives of Neurology · doi:10.1001/archneur.58.12.1985 · Cited by 4,781 · see citing works

Inflammation and Alzheimer’s disease

Akiyama, H. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00124-x · Cited by 4,514 · see citing works

Interleukin-8 and related chemotactic cytokines--CXC and CC chemokines.

Baggiolini, M., Dewald, B., & Moser, B. (1994) · PubMed · Cited by 2,232 · see citing works

Mild Cognitive Impairment Represents Early-Stage Alzheimer Disease

Morris, J. C., Storandt, M., Miller, J. P., McKeel, D. W., Price, J. L., Rubin, E. H., & Berg, L. (2001) · Archives of Neurology · doi:10.1001/archneur.58.3.397 · Cited by 1,833 · see citing works

Visualization of Aβ42(43) and Aβ40 in senile plaques with end-specific Aβ monoclonals: Evidence that an initially deposited species is Aβ42(43)

Iwatsubo, T., Odaka, A., Suzuki, N., Mizusawa, H., Nukina, N., & Ihara, Y. (1994) · Neuron · doi:10.1016/0896-6273(94)90458-8 · Cited by 1,774 · see citing works

Mild Cognitive Impairment as a Clinical Entity and Treatment Target

Petersen, R. C., & Morris, J. C. (2005) · Archives of Neurology · doi:10.1001/archneur.62.7.1160 · Cited by 935 · see citing works

Improved discrimination of AD patients using β-amyloid _(1-42) and tau levels in CSF

Hulstaert, F., Blennow, K., Ivanoiu, A., Schoonderwaldt, H. C., Riemenschneider, M., Deyn, P. P. D., Bancher, C., Cras, P., Wiltfang, J., Mehta, P. D., et al. (1999) · Neurology · doi:10.1212/wnl.52.8.1555 · Cited by 724 · see citing works

Intrathecal inflammation precedes development of Alzheimer's disease

Tarkowski, E. (2003) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.74.9.1200 · Cited by 501 · see citing works

The 9 year cognitive decline before dementia of the Alzheimer type: a prospective population-based study

Amieva, H., Jacqmin‐Gadda, H., Orgogozo, J., Carret, N. L., Helmer, C., Letenneur, L., Barberger‐Gateau, P., Fabrigoule, C., & Dartigues, J. (2005) · Brain · doi:10.1093/brain/awh451 · Cited by 437 · see citing works

Expression of chemokine receptors by subsets of neurons in the central nervous system

Horuk, R., Martin, A. W., Wang, Z., Schweitzer, L., Gerassimides, A., Guo, H.-D., Lu, Z., Hesselgesser, J., Perez, H. D., Kim, J., et al. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.158.6.2882 · Cited by 385 · see citing works

Controlled recruitment of monocytes and macrophages to specific organs through transgenic expression of monocyte chemoattractant protein-1

Fuentes, M. E., Durham, S. K., Swerdel, M. R., Lewin, A. C., Barton, D. S., Megill, J. R., Bravo, R., & Lira, S. A. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.155.12.5769 · Cited by 384 · see citing works

Expression of the chemokine receptor CXCR3 on neurons and the elevated expression of its ligand IP-10 in reactive astrocytes: in vitro ERK1/2 activation and role in Alzheimer’s disease

Xia, M. Q., Bacskai, B. J., Knowles, R. B., Qin, S. X., & Hyman, B. T. (2000) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(00)00285-x · Cited by 269 · see citing works

Chemokines/chemokine receptors in the central nervous system and Alzheimer's disease

Xia, M., & Hyman, B. T. (1999) · Journal of NeuroVirology · doi:10.3109/13550289909029743 · Cited by 269 · see citing works

Immunohistochemical Study of the β-Chemokine Receptors CCR3 and CCR5 and Their Ligands in Normal and Alzheimer's Disease Brains

Xia, M., Qin, S., Wu, L.-J., Mackay, C., & Hyman, B. (1998) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)65542-3 · Cited by 267 · see citing works

The interferon-stimulated response element and a kappa B site mediate synergistic induction of murine IP-10 gene transcription by IFN- gamma and TNF- alpha .

Ohmori, Y., & Hamilton, T. A. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.154.10.5235 · Cited by 248 · see citing works

Identification of monocyte chemoattractant protein‐1 in senile plaques and reactive microglia of Alzheimer's disease

ISHIZUKA, K., KIMURA, T., IGATA‐YI, R., KATSURAGI, S., TAKAMATSU, J., & MIYAKAWA, T. (1997) · Psychiatry and Clinical Neurosciences · doi:10.1111/j.1440-1819.1997.tb02375.x · Cited by 245 · see citing works

Trophic effects of interleukin-4, -7 and -8 on hippocampal neuronal cultures: potential involvement of glial-derived factors

Araujo, D. M., & Cotman, C. W. (1993) · Brain Research · doi:10.1016/0006-8993(93)90400-h · Cited by 237 · see citing works

Differential Production of and Migratory Response to Chemokines by Human Microglia and Astrocytes

Peterson, P. K., Hu, S., Salak‐Johnson, J. L., Molitor, T. W., & Chao, C. C. (1997) · The Journal of Infectious Diseases · doi:10.1093/infdis/175.2.478 · Cited by 209 · see citing works

Monocyte chemoattractant protein-1 is sufficient for the chemotaxis of monocytes and lymphocytes in transgenic mice but requires an additional stimulus for inflammatory activation

Gunn, M. D., Nelken, N. A., Liao, X., & Williams, L. T. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.158.1.376 · Cited by 205 · see citing works

Oxidative imbalance in patients with mild cognitive impairment and Alzheimer’s disease

GUIDI, I., GALIMBERTI, D., LONATI, S., NOVEMBRINO, C., BAMONTI, F., TIRITICCO, M., FENOGLIO, C., VENTURELLI, E., BARON, P., & BRESOLIN, N. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.01.001 · Cited by 203 · see citing works

Amyloid β(1–42) and phosphorylated tau in CSF as markers for early-onset Alzheimer disease

Schoonenboom, N. S. M., Pijnenburg, Y. A. L., Mulder, C., Rosso, S. M., van Elk, E. J., van Kamp, G. J., Swieten, J. C. V., & Scheltens, P. (2004) · Neurology · doi:10.1212/01.wnl.0000123249.58898.e0 · Cited by 181 · see citing works

Detailed assessment of activities of daily living in moderate to severe Alzheimer's disease

Galasko, D. R., Schmitt, F. A., Thomas, R. G., Jin, S., Bennett, D., & Ferris, S. H. (2005) · Journal of the International Neuropsychological Society · doi:10.1017/s1355617705050502 · Cited by 158 · see citing works

Interleukin-8 receptor B immunoreactivity in brain and neuritic plaques of Alzheimer's disease.

Xia, M., Qin, S., McNamara, M. J., Mackay, C. R., & Hyman, B. T. (1997) · Europe PMC (PubMed Central) · Cited by 131 · see citing works

Chemokines in serum and cerebrospinal fluid of Alzheimer's disease patients

Galimberti, D., Schoonenboom, N. S. M., Scarpini, E. A., & Scheltens, P. (2003) · Annals of Neurology · doi:10.1002/ana.10531 · Cited by 116 · see citing works

IP-10 and MCP-1 levels in CSF and serum from multiple sclerosis patients with different clinical subtypes of the disease

Scarpini, E. A., Galimberti, D., Baron, P., Clerici, R., Ronzoni, M., Conti, G. M., & Scarlato, G. (2002) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(01)00680-3 · Cited by 110 · see citing works

Monocyte chemoattractant protein-1 and macrophage inflammatory protein-2 are involved in both excitotoxin-induced neurodegeneration and regeneration

Kalehua, A. N., Nagel, J. E., Whelchel, L. M., Gides, J. J., Pyle, R. S., Smith, R., Kusiak, J. W., & Taub, D. D. (2004) · Experimental Cell Research · doi:10.1016/j.yexcr.2004.02.031 · Cited by 102 · see citing works

Intrathecal synthesis of monocyte chemoattractant protein-1 (MCP-1) in amyotrophic lateral sclerosis: further evidence for microglial activation in neurodegeneration

Wilms, H. (2003) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2003.08.042 · Cited by 100 · see citing works

MCP-1 in Alzheimer’s disease patients: A-2518G polymorphism and serum levels

Fenoglio, C., Galimberti, D., Lovati, C., Guidi, I., Gatti, A., Fogliarino, S., Tiriticco, M., Mariani, C. B., Forloni, G., Pettenati, C., et al. (2004) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2003.11.008 · Cited by 88 · see citing works

Intrathecal chemokine levels in Alzheimer disease and frontotemporal lobar degeneration

Galimberti, D., Schoonenboom, N. S. M., Scheltens, P., Fenoglio, C., Venturelli, E., Pijnenburg, Y. A. L., Bresolin, N., & Scarpini, E. A. (2006) · Neurology · doi:10.1212/01.wnl.0000191324.08289.9d · Cited by 82 · see citing works

CD8+ Myelin Peptide-Specific T Cells Can Chemoattract CD4+ Myelin Peptide-Specific T Cells: Importance of IFN-Inducible Protein 10

Biddison, W. E., Cruikshank, W. W., Pelfrey, C. M., Taub, D. D., & Turner, R. V. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.1.444 · Cited by 58 · see citing works

Qualitative assessment of intrathecal IgG synthesis by isoelectric focusing and immunodetection: Interlaboratory reproducibility and interobserver agreement

Sellebjerg, F. T., & Christiansen, M. (1996) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.3109/00365519609088600 · Cited by 56 · see citing works

The T-786C NOS3 polymorphism in Alzheimer's disease: Association and influence on gene expression

Venturelli, E., Galimberti, D., Lovati, C., Fenoglio, C., Scalabrini, D., Mariani, C. B., Forloni, G., Bresolin, N., & Scarpini, E. A. (2005) · Neuroscience Letters · doi:10.1016/j.neulet.2005.03.032 · Cited by 21 · see citing works

Inflammatory Proteins in Plasma and the Risk of Dementia: The Rotterdam Study

Engelhart, M. J., Geerlings, M. I., Meijer, J., Kiliaan, A., Ruitenberg, A., van Swieten, J. C., Stijnen, T., Hofman, A., Witteman, J. C. M., & Breteler, M. M. B. (2004) · Archives of Neurology · doi:10.1001/archneur.61.5.668 · Cited by 10 · see citing works

A Meta-Analysis of Cytokines in Alzheimer's Disease

Swardfager, W., Lanctôt, K., Rothenburg, L., Wong, A., Cappell, J., & Herrmann, N. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.06.012 · Cited by 1,108 · see citing works

Classification and prediction of clinical Alzheimer's diagnosis based on plasma signaling proteins

Ray, S., Britschgi, M., Herbert, C., Takeda-Uchimura, Y., Boxer, A., Blennow, K., Friedman, L. F., Galasko, D. R., Jutel, M., Karydas, A., et al. (2007) · Nature Medicine · doi:10.1038/nm1653 · Cited by 1,048 · see citing works

The blood-brain barrier in Alzheimer’s disease

Zenaro, E., Piacentino, G., & Constantin, G. (2017) · Neurobiology of Disease · doi:10.1016/j.nbd.2016.07.007 · Cited by 767 · see citing works

Mediterranean Diet and Mild Cognitive Impairment

Scarmeas, N., Stern, Y., Mayeux, R., Manly, J. J., Schupf, N., & Luchsinger, J. A. (2009) · Archives of Neurology · doi:10.1001/archneurol.2008.536 · Cited by 757 · see citing works

sTREM2 cerebrospinal fluid levels are a potential biomarker for microglia activity in early‐stage Alzheimer's disease and associate with neuronal injury markers

Suárez‐Calvet, M., Kleinberger, G., Araque Caballero, M. Á., Brendel, M., Rominger, A., Alcolea, D., Fortea, J., Lleó, A., Blesa, R., Gispert, J. D., et al. (2016) · EMBO Molecular Medicine · doi:10.15252/emmm.201506123 · Cited by 522 · see citing works

Current state of Alzheimer’s fluid biomarkers

Molinuevo, J. L., Ayton, S., Batrla, R., Bednar, M. M., Bittner, T., Cummings, J., Fagan, A. M., Hampel, H., Mielke, M. M., Mikulskis, A., et al. (2018) · Acta Neuropathologica · doi:10.1007/s00401-018-1932-x · Cited by 518 · see citing works

Body Fluid Cytokine Levels in Mild Cognitive Impairment and Alzheimer’s Disease: a Comparative Overview

Brosseron, F., Krauthausen, M., Kummer, M., & Heneka, M. T. (2014) · Molecular Neurobiology · doi:10.1007/s12035-014-8657-1 · Cited by 447 · see citing works

Transcranial direct current stimulation improves recognition memory in Alzheimer disease

Ferrucci, R., Mameli, F., Guidi, I., Mrakic‐Sposta, S., Vergari, M., Marceglia, S. R. F., Cogiamanian, F. M., Barbieri, S., Scarpini, E. A., & Priori, A. (2008) · Neurology · doi:10.1212/01.wnl.0000317060.43722.a3 · Cited by 457 · see citing works

The contribution of neuroinflammation to amyloid toxicity in Alzheimer's disease

Minter, M. R., Taylor, J. M., & Crack, P. J. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13411 · Cited by 451 · see citing works

The role of monocyte chemoattractant protein MCP1/CCL2 in neuroinflammatory diseases

Conductier, G., Blondeau, N., Guyon, A., Nahon, J., & Rovère, C. (2010) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2010.05.010 · Cited by 405 · see citing works

Deletion of tumor necrosis factor death receptor inhibits amyloid β generation and prevents learning and memory deficits in Alzheimer's mice

He, P., Zhong, Z., Lindholm, K., Berning, L., Lee, W., Lemere, C., Staufenbiel, M., Li, R., & Shen, Y. (2007) · The Journal of Cell Biology · doi:10.1083/jcb.200705042 · Cited by 390 · see citing works

Neuroinflammation: Implications for the Pathogenesis and Molecular Diagnosis of Alzheimer's Disease

Rojo, L. E., Fernández, J. A., Maccioni, A. A., Jimenez, J. M., & Maccioni, R. B. (2008) · Archives of Medical Research · doi:10.1016/j.arcmed.2007.10.001 · Cited by 351 · see citing works

CXCR3 ligands in disease and therapy

Raemdonck, K. V., den Steen, P. E. V., Liekens, S., Damme, J. V., & Struyf, S. (2014) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2014.11.009 · Cited by 313 · see citing works

Diet and Alzheimer’s disease risk factors or prevention: the current evidence

Solfrizzi, V., Panza, F., Frisardi, V., Seripa, D., Logroscino, G., Imbimbo, B. P., & Pilotto, A. (2011) · Expert Review of Neurotherapeutics · doi:10.1586/ern.11.56 · Cited by 298 · see citing works

Glial activation and inflammation along the Alzheimer’s disease continuum

Nordengen, K., Kirsebom, B.-E., Henjum, K., Selnes, P., Gísladóttir, B., Wettergreen, M., Torsetnes, S. B., Grøntvedt, G. R., Waterloo, K. K., Aarsland, D., et al. (2019) · Journal of Neuroinflammation · doi:10.1186/s12974-019-1399-2 · Cited by 274 · see citing works

Role of inflammatory molecules in the Alzheimer's disease progression and diagnosis

Bagyinszky, E., Giau, V. V., Shim, K., Suk, K., An, S. S. A., & Kim, S. (2017) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2017.03.031 · Cited by 265 · see citing works

Manifestations of systemic lupus erythematosus.

Cojocaru, M., Cojocaru, I. M., Siloşi, I., & Vrabie, C. D. (2011) · PubMed Central · Cited by 261 · see citing works

Chemokines and chemokine receptors in mood disorders, schizophrenia, and cognitive impairment: A systematic review of biomarker studies

Stuart, M. J., & Baune, B. T. (2014) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2014.02.001 · Cited by 258 · see citing works

Monocyte Chemoattractant Protein‐1 Plays a Dominant Role in the Chronic Inflammation Observed in Alzheimer's Disease

Sokolova, A., Hill, M. D., Rahimi, F., Warden, L. A., Halliday, G. M., & Shepherd, C. E. (2009) · Brain Pathology · doi:10.1111/j.1750-3639.2008.00188.x · Cited by 249 · see citing works

Cerebrospinal fluid and serum biomarkers of cerebral malaria mortality in Ghanaian children

Armah, H. B., Wilson, N. O., Sarfo, B. Y., Powell, M. D., Bond, V. C., Anderson, W. A., Adjei, A. A., Gyasi, R. K., Tettey, Y., Wiredu, E. K., et al. (2007) · Malaria Journal · doi:10.1186/1475-2875-6-147 · Cited by 239 · see citing works

Molecular biomarkers of Alzheimer's disease: progress and prospects

Lashley, T., Schott, J. M., Weston, P. S. J., Murray, C. E., Wellington, H., Keshavan, A., Foti, S. C., Foiani, M. S., Toombs, J., Rohrer, J. D., et al. (2018) · Disease Models & Mechanisms · doi:10.1242/dmm.031781 · Cited by 233 · see citing works

Circulating miRNAs as Potential Biomarkers in Alzheimer's Disease

Galimberti, D., Villa, C., Fenoglio, C., Serpente, M., Ghezzi, L., Cioffi, S. M. G., Arighi, A., Fumagalli, G., & Scarpini, E. (2014) · Journal of Alzheimer’s Disease · doi:10.3233/jad-140756 · Cited by 222 · see citing works

Biomarkers of Oxidative Damage and Inflammation in Alzheimer's Disease

Galasko, D. R., & Montine, T. J. (2010) · Biomarkers in Medicine · doi:10.2217/bmm.09.89 · Cited by 221 · see citing works

Infiltrating CD8+ T cells exacerbate Alzheimer’s disease pathology in a 3D human neuroimmune axis model

Jorfi, M., Park, J., Hall, C. K., Lin, C.-C. J., Chen, M., von Maydell, D., Kruskop, J. M., Kang, B., Choi, Y., Prokopenko, D., et al. (2023) · Nature Neuroscience · doi:10.1038/s41593-023-01415-3 · Cited by 214 · see citing works

Inflammatory biomarkers in Alzheimer's disease plasma

Morgan, A. R., Touchard, S., Leckey, C. A., O’Hagan, C., Nevado‐Holgado, A. J., Barkhof, F., Bertram, L., Blin, O. J., Bos, I., Dobričić, V., et al. (2019) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2019.03.007 · Cited by 207 · see citing works

Levels of β-Secretase (BACE1) in Cerebrospinal Fluid as a Predictor of Risk in Mild Cognitive Impairment

Zhong, Z., Ewers, M., Teipel, S., Bürger, K., Wallin, A., Blennow, K., He, P., McAllister, C., Hampel, H., & Shen, Y. (2007) · Archives of General Psychiatry · doi:10.1001/archpsyc.64.6.718 · Cited by 206 · see citing works

Proinflammatory and anti-inflammatory cytokines in the CSF of patients with Alzheimer's disease and their correlation with cognitive decline

Taipa, R., das Neves, S. P., Sousa, A. L., Fernandes, J., Pinto, C., Correia, A. P., Santos, E., Pinto, P. S., Carneiro, P., Costa, P., et al. (2019) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2018.12.019 · Cited by 205 · see citing works

Physical Exercise in MCI Elderly Promotes Reduction of Pro-Inflammatory Cytokines and Improvements on Cognition and BDNF Peripheral Levels

Nascimento, C. M. C., Pereira, J., de Andrade, L. P., Garuffi, M., Talib, L. L., Forlenza, O. V., Carral, J. M. C., Cominetti, M. R., & Stella, F. (2014) · Current Alzheimer Research · doi:10.2174/156720501108140910122849 · Cited by 195 · see citing works

Plasma MCP-1 and Cognitive Decline in Patients with Alzheimer’s Disease and Mild Cognitive Impairment: A Two-year Follow-up Study

Lee, W., Liao, Y., Wang, Y.-F., Lin, I.-F., Wang, S., & Fuh, J. (2018) · Scientific Reports · doi:10.1038/s41598-018-19807-y · Cited by 193 · see citing works

Peripheral inflammation in prodromal Alzheimer’s and Lewy body dementias

King, E., O'Brien, J. T., Donaghy, P. C., Morris, C. M., Barnett, N. A., Olsen, K., Martin-Ruiz, C. M., Taylor, J., & Thomas, A. J. (2017) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2017-317134 · Cited by 187 · see citing works

Interleukin‐6 and chemokines in the neuropsychiatric manifestations of systemic lupus erythematosus

Fragoso-Loyo, H. E., Richaud‐Patín, Y., Orozco-Narváez, A., Dávila-Maldonado, L., Atisha‐Fregoso, Y., Llorente, L., & Sánchez‐Guerrero, J. (2007) · Arthritis & Rheumatism · doi:10.1002/art.22451 · Cited by 185 · see citing works

Role of Oxidative Damage in Alzheimer’s Disease and Neurodegeneration: From Pathogenic Mechanisms to Biomarker Discovery

Buccellato, F. R., D’Anca, M., Fenoglio, C., Scarpini, E., & Galimberti, D. (2021) · Antioxidants · doi:10.3390/antiox10091353 · Cited by 179 · see citing works

Plasma IP-10, apoptotic and angiogenic factors associated with fatal cerebral malaria in India

Jain, V., Armah, H. B., Tongren, J. E., Ned, R. M., Wilson, N. O., Crawford, S. B., Joel, P. K., Singh, M. P., Nagpal, A. C., Dash, A., et al. (2008) · Malaria Journal · doi:10.1186/1475-2875-7-83 · Cited by 177 · see citing works

Amyloid deposition and inflammation in APPswe/PS1dE9 mouse model of Alzheimer's disease.

Ruan, L., Kang, Z., Pei, G., & Le, Y. (2009) · Current Alzheimer Research · doi:10.2174/156720509790147070 · Cited by 181 · see citing works

Cerebrospinal Fluid Biomarkers of Alzheimer’s Disease: Current Evidence and Future Perspectives

McGrowder, D. A., Miller, F. G., Vaz, K., Nwokocha, C. R., Wilson-Clarke, C. F., Anderson, M., Brown, J., Anderson-Jackson, L., Williams, L., Latore, L., et al. (2021) · Brain Sciences · doi:10.3390/brainsci11020215 · Cited by 167 · see citing works

Alpha-Synuclein Proteins Promote Pro-Inflammatory Cascades in Microglia: Stronger Effects of the A53T Mutant

Hoenen, C., Gustin, A., Birck, C., Kirchmeyer, M., Beaume, N., Felten, P., Grandbarbe, L., Heuschling, P., & Heurtaux, T. (2016) · PLOS ONE · doi:10.1371/journal.pone.0162717 · Cited by 159 · see citing works

Distinctive Effects of Aerobic and Resistance Exercise Modes on Neurocognitive and Biochemical Changes in Individuals with Mild Cognitive Impairment

Tsai, C., Pai, M., Ukropec, J., & Ukropcová, B. (2019) · Current Alzheimer Research · doi:10.2174/1567205016666190228125429 · Cited by 160 · see citing works

Increased production of inflammatory cytokines in mild cognitive impairment

Magaki, S., Mueller, C., DICKSON, C., & Kirsch, W. M. (2006) · Experimental Gerontology · doi:10.1016/j.exger.2006.09.015 · Cited by 156 · see citing works

Cerebrospinal Fluid Cytokine Levels and Cognitive Impairment in Cerebral Malaria

John, C. C., Panoskaltsis‐Mortari, A., Opoka, R. O., Park, G. S., Orchard, P. J., Jurek, A. M., Idro, R., Byarugaba, J. S., & Boivin, M. J. (2008) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2008.78.198 · Cited by 154 · see citing works

Differential expression of cytokines in breast cancer patients receiving different chemotherapies: implications for cognitive impairment research

Janelsins, M. C., Mustian, K. M., Palesh, O. G., Mohile, S. G., Peppone, L. J., Sprod, L. K., Heckler, C. E., Roscoe, J. A., Katz, A. W., Williams, J. P., et al. (2011) · Supportive Care in Cancer · doi:10.1007/s00520-011-1158-0 · Cited by 150 · see citing works

RANTES upregulation in the Alzheimer's disease brain: A possible neuroprotective role

Tripathy, D., Thirumangalakudi, L., & Grammas, P. (2008) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2008.03.009 · Cited by 150 · see citing works

Biomarkers used in Alzheimer’s disease diagnosis, treatment, and prevention

Mahaman, Y. A. R., Embaye, K. S., Huang, F., Li, L., Zhu, F., Wang, J.-Z., Liu, R., Feng, J., & Wang, X. (2022) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101544 · Cited by 149 · see citing works

CXCR3 promotes plaque formation and behavioral deficits in an Alzheimer’s disease model

Krauthausen, M., Kummer, M. P., Zimmermann, J., Reyes-Irisarri, E., Terwel, D., Bulic, B., Heneka, M. T., & Müller, M. (2014) · Journal of Clinical Investigation · doi:10.1172/jci66771 · Cited by 147 · see citing works

Biomarkers as Predictors for Conversion from Mild Cognitive Impairment to Alzheimer-Type Dementia: Implications for Trial Design

van Rossum, I. A., Vos, S. J. B., Handels, R. L. H., & Visser, P. J. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-091606 · Cited by 143 · see citing works

Blood-Based Biomarkers for Alzheimer’s Disease Diagnosis and Progression: An Overview

Varesi, A., Carrara, A., Pires, V. G., Floris, V., Pierella, E., Savioli, G., Prasad, S., Esposito, C., Ricevuti, G., Chirumbolo, S., et al. (2022) · Cells · doi:10.3390/cells11081367 · Cited by 142 · see citing works

Markers of neuroinflammation associated with Alzheimer’s disease pathology in older adults

Popp, J., Oikonomidi, A., Tautvydaitė, D., Dayon, L., Bacher, M., Migliavacca, E., Henry, H., Kirkland, R., Severin, I., Wojcik, J., et al. (2017) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2017.01.020 · Cited by 136 · see citing works

Distinct cytokine profiles in human brains resilient to Alzheimer's pathology

Barroeta-Espar, I., Weinstock, L. D., Perez-Nievas, B. G., Meltzer, A. C., Siao Tick Chong, M., Amaral, A. C., Murray, M. E., Moulder, K. L., Morris, J. C., Cairns, N. J., et al. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2018.10.009 · Cited by 133 · see citing works

Inflammatory Markers and Their Association with Post Stroke Cognitive Decline

Narasimhalu, K., Lee, J. H., Leong, Y.-L., Ma, L., Silva, D. A. D., Wong, M.-C., Chang, H., & Chen, C. (2013) · International Journal of Stroke · doi:10.1111/ijs.12001 · Cited by 132 · see citing works

Dietary inulin alters the gut microbiome, enhances systemic metabolism and reduces neuroinflammation in an APOE4 mouse model

Hoffman, J. D., Yanckello, L. M., Chlipala, G. E., Hammond, T. C., McCulloch, S. D., Parikh, I. J., Sun, S., Morganti, J. M., Green, S. J., & Lin, A. (2019) · PLoS ONE · doi:10.1371/journal.pone.0221828 · Cited by 129 · see citing works

Dysregulated Gut Homeostasis Observed Prior to the Accumulation of the Brain Amyloid-β in Tg2576 Mice

Honarpisheh, P., Reynolds, C. R., Conesa, M. P. B., Moruno-Manchon, J. F., Putluri, N., Bhattacharjee, M. B., Urayama, A., McCullough, L. D., & Ganesh, B. P. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21051711 · Cited by 127 · see citing works

Abnormalities in serum chemokine levels in euthymic patients with Bipolar Disorder

Brietzke, E. M., Kauer‐Sant’Anna, M., Teixeira, A. L., & Kapczinski, F. P. (2009) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2009.04.008 · Cited by 127 · see citing works

Osteopontin is Increased in the Cerebrospinal Fluid of Patients with Alzheimer's Disease and Its Levels Correlate with Cognitive Decline

Comi, C., Carecchio, M., Chiocchetti, A., Nicola, S., Galimberti, D., Fenoglio, C., Cappellano, G., Monaco, F., Scarpini, E., & Dianzani, U. (2010) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-1309 · Cited by 120 · see citing works

A deficiency in CCR2+ monocytes: the hidden side of Alzheimer’s disease

Naert, G., & Rivest, S. (2013) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjt028 · Cited by 123 · see citing works

Cerebrospinal Fluid Biomarkers of Neurovascular Dysfunction in Mild Dementia and Alzheimer'S Disease

Sweeney, M. D., Sagare, A. P., & Zlokovic, B. V. (2015) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2015.76 · Cited by 122 · see citing works

Longitudinal changes of CSF biomarkers in memory clinic patients

Bouwman, F. H., van der Flier, W. M., Schoonenboom, N. S. M., van Elk, E. J., Kok, A., Rijmen, F., Blankenstein, M. A., & Scheltens, P. (2007) · Neurology · doi:10.1212/01.wnl.0000271375.37131.04 · Cited by 120 · see citing works

Increased plasma levels of lipocalin 2 in mild cognitive impairment

Choi, J., Lee, H., & Suk, K. (2011) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2011.03.023 · Cited by 119 · see citing works

Early intraneuronal amyloid triggers neuron-derived inflammatory signaling in APP transgenic rats and human brain

Welikovitch, L. A., Do Carmo, S., Maglóczky, Z., Malcolm, J. C., Lőke, J., Klein, W. L., Freund, T., & Cuello, A. C. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1914593117 · Cited by 116 · see citing works

Roles of Microglial and Monocyte Chemokines and Their Receptors in Regulating Alzheimer's Disease-Associated Amyloid-β and Tau Pathologies

Guedes, J. R., Lao, T., Cardoso, A. L., & El Khoury, J. (2018) · Frontiers in Neurology · doi:10.3389/fneur.2018.00549 · Cited by 115 · see citing works

Cerebrospinal fluid biomarkers for understanding multiple aspects of Alzheimer’s disease pathogenesis

Dhiman, K., Blennow, K., Zetterberg, H., Martins, R., & Gupta, V. (2019) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03040-5 · Cited by 97 · see citing works

CCL2 Accelerates Microglia-Mediated Aβ Oligomer Formation and Progression of Neurocognitive Dysfunction

Kiyota, T., Yamamoto, M., Xiong, H., Lambert, M. P., Klein, W. L., Gendelman, H. E., Ransohoff, R. M., & Ikezu, T. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006197 · Cited by 114 · see citing works

The Inflammatory Marker YKL-40 Is Elevated in Cerebrospinal Fluid from Patients with Alzheimer’s but Not Parkinson’s Disease or Dementia with Lewy Bodies

Wennström, M., Surova, Y., Hall, S., Nilsson, C., Minthon, L., Hansson, O., & Nielsen, H. M. (2015) · PLoS ONE · doi:10.1371/journal.pone.0135458 · Cited by 114 · see citing works

Intravenous Immunoglobulins in Refractory Childhood‐Onset Epilepsy: Effects on Seizure Frequency, EEG Activity, and Cerebrospinal Fluid Cytokine Profile

Billiau, A., Witters, P., Ceulemans, B., Kasran, A., Wouters, C. H., & Lagae, L. G. (2007) · Epilepsia · doi:10.1111/j.1528-1167.2007.01134.x · Cited by 109 · see citing works

Role of interleukin 8 in depression and other psychiatric disorders

Tsai, S. (2020) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2020.110173 · Cited by 107 · see citing works

Biomarkers in Sporadic and Familial Alzheimer’s Disease

Lista, S., O’Bryant, S. E., Blennow, K., Dubois, B., Hugon, J., Zetterberg, H., & Hampel, H. (2015) · Journal of Alzheimer's Disease · doi:10.3233/jad-143006 · Cited by 106 · see citing works

Systemic and Acquired Immune Responses in Alzheimer's Disease

Britschgi, M., & Wyss‐Coray, T. (2007) · International review of neurobiology · doi:10.1016/s0074-7742(07)82011-3 · Cited by 105 · see citing works

Expression Profiles of Cytokines in the Brains of Alzheimer's Disease (AD) Patients Compared to the Brains of Non-Demented Patients with and without Increasing AD Pathology

Morimoto, K., Horio, J., Satoh, H., Sue, L. I., Beach, T. G., Arita, S., Tooyama, I., & Konishi, Y. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-101815 · Cited by 104 · see citing works

CXCL4 and CXCL10 Predict Risk of Fatal Cerebral Malaria

Wilson, N. O., Jain, V., Roberts, C. E., Lucchi, N. W., Joel, P. K., Singh, M. P., Nagpal, A. C., Dash, A. P., Udhayakumar, V., Singh, N., et al. (2011) · Disease Markers · doi:10.1155/2011/828256 · Cited by 104 · see citing works

Cerebrospinal Fluid and Plasma Levels of Inflammation Differentially Relate to CNS Markers of Alzheimer’s Disease Pathology and Neuronal Damage

Bettcher, B. M., Johnson, S. C., Fitch, R., Casaletto, K. B., Heffernan, K. S., Asthana, S., Zetterberg, H., Blennow, K., Carlsson, C. M., Neuhaus, J. M., et al. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-170602 · Cited by 103 · see citing works

Associations between inflammatory markers and cognitive function in breast cancer patients receiving chemotherapy

Williams, A. M., Shah, R., Shayne, M., Huston, A. J., Krebs, M., Murray, N., Thompson, B. D., Doyle, K., Korotkin, J. E., van Wijngaarden, E., et al. (2017) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2017.10.005 · Cited by 100 · see citing works

Impact of peripheral levels of chemokines, BDNF and oxidative markers on cognition in individuals with schizophrenia

Asevedo, E. D. M., Gadelha, A., Noto, C. D. S., Mansur, R. B., Zugman, A., Belangero, S. I., Berberian, A. D. A., Scarpato, B. S., Leclerc, E., Teixeira, A. L., et al. (2013) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2013.05.032 · Cited by 99 · see citing works

The complex contribution of chemokines to neuroinflammation: switching from beneficial to detrimental effects

Thuc, O. L., Blondeau, N., Nahon, J., & Rovère, C. (2015) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12855 · Cited by 98 · see citing works

Preconditioning of Microglia by α-Synuclein Strongly Affects the Response Induced by Toll-like Receptor (TLR) Stimulation

Roodveldt, C., Labrador‐Garrido, A., González‐Rey, E., Lachaud, C. C., Guilliams, T., Fernández-Montesinos, R., Benitez-Rondan, A., Robledo, G., Hmadcha, A., Delgado, M., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0079160 · Cited by 96 · see citing works

Increased peripheral inflammation in asymptomatic leucine‐rich repeat kinase 2 mutation carriers

Dzamko, N., Rowe, D. B., & Halliday, G. M. (2016) · Movement Disorders · doi:10.1002/mds.26529 · Cited by 98 · see citing works

Transcriptome Changes in the Alzheimer’s Disease Middle Temporal Gyrus: Importance of RNA Metabolism and Mitochondria-Associated Membrane Genes

Piras, I. S., Krate, J., Delvaux, E., Nolz, J., Mastroeni, D., Persico, A. M., Jepsen, W. M., Beach, T. G., Huentelman, M. J., & Coleman, P. D. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-181113 · Cited by 98 · see citing works

Role of Chemokines in the Development and Progression of Alzheimer’s Disease

Wojcieszak, J., Kuczyńska, K., & Zawilska, J. B. (2022) · Journal of Molecular Neuroscience · doi:10.1007/s12031-022-02047-1 · Cited by 97 · see citing works

The Role of Macrophage Migration Inhibitory Factor in Alzheimer’s Disease

Bacher, M., Deuster, O., Aljabari, B., Egensperger, R., Neff, F., Jessen, F., Popp, J., Noelker, C., Reese, J. P., Al‐Abed, Y., et al. (2010) · Molecular Medicine · doi:10.2119/molmed.2009.00123 · Cited by 95 · see citing works

From Cerebrospinal Fluid to Blood: The Third Wave of Fluid Biomarkers for Alzheimer’s Disease

Zetterberg, H., & Blennow, K. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-179926 · Cited by 94 · see citing works

Intrathecal levels of IL-6, IL-11 and LIF in Alzheimer's disease and frontotemporal lobar degeneration

Galimberti, D., Venturelli, E., Fenoglio, C., Guidi, I., Villa, C., Bergamaschini, L. C., Cortini, F., Scalabrini, D., Baron, P., Vergani, C., et al. (2008) · Journal of Neurology · doi:10.1007/s00415-008-0737-6 · Cited by 94 · see citing works

Mediterranean Diet in Predementia and Dementia Syndromes

Solfrizzi, V., Frisardi, V., Seripa, D., Logroscino, G., Imbimbo, B. P., D’Onofrio, G., Addante, F., Sancarlo, D., Cascavilla, L., Pilotto, A., et al. (2011) · Current Alzheimer Research · doi:10.2174/156720511796391809 · Cited by 91 · see citing works

Macrophage migration inhibitory factor in mild cognitive impairment and Alzheimer’s disease

Popp, J., Bacher, M., Kölsch, H., Noelker, C., Deuster, O., Dodel, R. C., & Jessen, F. (2008) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2008.10.006 · Cited by 91 · see citing works

CCL2 affects β-amyloidosis and progressive neurocognitive dysfunction in a mouse model of Alzheimer's disease

Kiyota, T., Gendelman, H. E., Weir, R. A., Higgins, E. E., Zhang, G., & Jain, M. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2012.08.009 · Cited by 90 · see citing works

Preoperative cerebrospinal fluid cytokine levels and the risk of postoperative delirium in elderly hip fracture patients

Westhoff, D., Witlox, J., Koenderman, L., Kalisvaart, K. J., de Jonghe, J. F. M., van Stijn, M. F. M., Houdijk, A. P. J., Hoogland, I. C. M., MacLullich, A. M. J., van Westerloo, D. J., et al. (2013) · Journal of Neuroinflammation · doi:10.1186/1742-2094-10-122 · Cited by 90 · see citing works

The Potential Role of Chemokines in Alzheimer’s Disease Pathogenesis

Azizi, G., Hossein‐Khannazer, N., & Mirshafiey, A. (2014) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.1177/1533317513518651 · Cited by 89 · see citing works

Histone Deacetylases Enzyme, Copper, and IL-8 Levels in Patients With Alzheimer’s Disease

Alsadany, M. A., Shehata, H. H., Mohamad, M. I., & Mahfouz, R. (2012) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.1177/1533317512467680 · Cited by 87 · see citing works

Increased Levels of Chitotriosidase and YKL-40 in Cerebrospinal Fluid from Patients with Alzheimer's Disease

Rosén, C., Andersson, C.-H., Andréasson, U., Molinuevo, J. L., Bjerke, M., Rami, L., Lladó, A., Blennow, K., & Zetterberg, H. (2014) · Dementia and Geriatric Cognitive Disorders Extra · doi:10.1159/000362164 · Cited by 87 · see citing works

Innate immune system and inflammation in Alzheimer’s disease: From pathogenesis to treatment

Serpente, M., Bonsi, R., Scarpini, E., & Galimberti, D. (2014) · Neuroimmunomodulation · doi:10.1159/000356529 · Cited by 87 · see citing works

Decreased IL-8 levels in CSF and serum of AD patients and negative correlation of MMSE and IL-1β

Hesse, R., Wahler, A., Gummert, P., Kirschmer, S., Otto, M., Tumani, H., Lewerenz, J., Schnack, C., & Arnim, C. A. F. V. (2016) · BMC Neurology · doi:10.1186/s12883-016-0707-z · Cited by 85 · see citing works

Profiling Microglia From Alzheimer’s Disease Donors and Non-demented Elderly in Acute Human Postmortem Cortical Tissue

Alsema, A. M., Jiang, Q., Kracht, L., Gerrits, E., Dubbelaar, M. L., Miedema, A., Brouwer, N., Hol, E. M., Middeldorp, J., van Dijk, R. E., et al. (2020) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2020.00134 · Cited by 79 · see citing works

Periodontitis Induced by P. gingivalis-LPS Is Associated With Neuroinflammation and Learning and Memory Impairment in Sprague-Dawley Rats

Hu, Y., Li, H., Zhang, J., Zhang, X., Xia, X., Qiu, C., Liao, Y., Chen, H., Song, Z., & Zhou, W. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00658 · Cited by 81 · see citing works

Pharmacological antagonism of interleukin-8 receptor CXCR2 inhibits inflammatory reactivity and is neuroprotective in an animal model of Alzheimer’s disease

Ryu, J. K., Cho, T., Choi, H. B., Jantaratnotai, N., & McLarnon, J. G. (2015) · Journal of Neuroinflammation · doi:10.1186/s12974-015-0339-z · Cited by 81 · see citing works

Latest advances in cerebrospinal fluid and blood biomarkers of Alzheimer’s disease

Milà‐Alomà, M., Suárez‐Calvet, M., & Molinuevo, J. L. (2019) · Therapeutic Advances in Neurological Disorders · doi:10.1177/1756286419888819 · Cited by 78 · see citing works

Association between Helicobacter pylori infection and mild cognitive impairment

Kountouras, J., Tsolaki, M., Boziki, M. K., Gavalas, E., Zavos, C., Stergiopoulos, C., Kapetanakis, N., Chatzopoulos, D., & Venizelos, I. (2007) · European Journal of Neurology · doi:10.1111/j.1468-1331.2007.01827.x · Cited by 80 · see citing works

Activation of the nuclear receptor PPARδ is neuroprotective in a transgenic mouse model of Alzheimer’s disease through inhibition of inflammation

Malm, T., Mariani, M., Donovan, L. J., Neilson, L., & Landreth, G. E. (2015) · Journal of Neuroinflammation · doi:10.1186/s12974-014-0229-9 · Cited by 77 · see citing works

Chlamydia pneumoniae: An Etiologic Agent for Late-Onset Dementia

Balin, B. J., Hammond, C. J., Little, C. S., Hingley, S. T., Al-Atrache, Z., Appelt, D. M., Whittum-Hudson, J. A., & Hudson, A. P. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00302 · Cited by 77 · see citing works

Correlation between Serum RANTES Levels and the Severity of Parkinson’s Disease

Tang, P., Li, C., Li, X., Liu, Y., Liu, P., Hou, C., & Li, R. (2014) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2014/208408 · Cited by 77 · see citing works

Blood and CSF chemokines in Alzheimer’s disease and mild cognitive impairment: a systematic review and meta-analysis

Zhou, F., Sun, Y., Xie, X., & Zhao, Y. (2023) · Alzheimer s Research & Therapy · doi:10.1186/s13195-023-01254-1 · Cited by 75 · see citing works

IL-8 Induces Expression of Matrix Metalloproteinases, Cell Cycle and Pro-Apoptotic Proteins, and Cell Death in Cultured Neurons

Thirumangalakudi, L., Yin, L., Rao, H. V., & Grammas, P. (2007) · Journal of Alzheimer s Disease · doi:10.3233/jad-2007-11307 · Cited by 73 · see citing works

Endoplasmic reticulum stress-regulated CXCR3 pathway mediates inflammation and neuronal injury in acute glaucoma

Ha, Y., Liu, H., Xu, Z., Yokota, H., Narayanan, S. P., Lemtalsi, T., Smith, S. B., Caldwell, R. W., Caldwell, R. B., & Zhang, W. (2015) · Cell Death and Disease · doi:10.1038/cddis.2015.281 · Cited by 73 · see citing works

Associations of neuroinflammatory IL-6 and IL-8 with brain atrophy, memory decline, and core AD biomarkers – in cognitively unimpaired older adults

Capogna, E., Watne, L. O., Sørensen, Ø., Guichelaar, C. J., Idland, A., Halaas, N. B., Blennow, K., Zetterberg, H., Walhovd, K. B., Fjell, A. M., et al. (2023) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2023.06.027 · Cited by 73 · see citing works

Tooth loss is associated with mild memory impairment in the elderly: The Fujiwara-kyo study

Okamoto, N., Morikawa, M., Okamoto, K., Habu, N., Hazaki, K., Harano, A., Iwamoto, J., Tomioka, K., Saeki, K., & Kurumatani, N. (2010) · Brain Research · doi:10.1016/j.brainres.2010.06.054 · Cited by 66 · see citing works

P2–138: Chemokine serum levels in mild cognitive impairment as Alzheimer's disease early biomarkers

Galimberti, D., Fenoglio, C., Lovati, C., Venturelli, E., Guidi, I., Corrà, B., Scalabrini, D., Clerici, F., Mariani, C. B., Bresolin, N., et al. (2006) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2006.05.976

P2‐009: The chemokines IL8 and MIP‐1b distinguish mild cognitive impairment from early stage Alzheimer's disease

Gonçalves, M., Santana, I. J., Francisco, N., Cunha, C., Batista, S., Kodandaraman, G., & Souto‐Carneiro, M. (2012) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2012.05.712

P1–218: Cerebrospinal fluid chemokine levels in healthy older adults: Relationship to beta‐amyloid and tau indices

Pomara, N., Nierenberg, J. J., Sidtis, J. J., Zetterberg, H., & Blennow, K. (2013) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2013.05.442 · Cited by 1 · see citing works

Increased intrathecal chemokine synthesis in MCI and mild AD patients. Implications in the pathogenesis and relevance for early diagnosis

Scarpini, E. A., Galimberti, D., Schoonenboom, N. S. M., Fenoglio, C., Venturelli, E., & Bresolin, N. (2005)

Increased production of inflammatory cytokines in mild cognitive impairment

Magaki, S., Mueller, C., DICKSON, C., & Kirsch, W. M. (2006) · Experimental Gerontology · doi:10.1016/j.exger.2006.09.015 · Cited by 156 · see citing works